clinicaltrialsimagingnetwork.com

What It Is

Clinical Trials Imaging Network (CTIN) is a patented software system designed for imaging assessment workflows in clinical trials, with the goal of improving collaboration between radiologists and oncologists. Its core value is bringing imaging measurements, automated treatment response calculations, images, clinical response data, and electronic sign-off into a cloud-based reporting environment, improving the efficiency, accuracy, and auditability of imaging data in clinical trials.

Core Features and Collaboration

Based on publicly available information, CTIN is not positioned as a general-purpose project management tool. Instead, it focuses on oncology clinical trial image review and treatment response assessment. Oncologists can view measurement results, automated response calculations, images, and electronic sign-offs through an easy-to-use interface, while radiology teams can continue using their existing workflows for image analysis and send key data into the cloud-based reporting software. The website also mentions bidirectional interaction with radiology dictation systems, which has practical value for reducing duplicate data entry and improving report consistency.

Pricing, Security, and Deployment

The website does not disclose plans, pricing, free trials, or payment methods, so procurement will most likely require contacting the sales or project team. In terms of deployment, the text explicitly refers to “cloud-based reporting software,” indicating that it provides at least cloud reporting capabilities, but it does not clarify whether private deployment, self-hosting, or specific data regions are supported. For security and compliance, it only mentions electronically auditable formats and electronic sign-off, without listing specific certifications or controls such as HIPAA, SOC 2, or 21 CFR Part 11. Healthcare organizations should therefore verify compliance documentation carefully before purchasing.

Pros, Cons, and Best-Fit Users

CTIN’s strength is its highly focused use case. It is well suited to oncology clinical trial teams that require rigorous imaging assessment, treatment response calculation, and auditable data trails. It was developed by University Radiology Group and is supported by a large radiology services team, which also strengthens its professional credibility. The main drawback is the limited amount of public information: there is little transparency around APIs, permission models, integration lists, implementation case studies, or pricing, making it harder to quickly evaluate total cost of ownership.

Access from China and Alternatives

Access from China is unknown, and network connectivity, cross-border data compliance, payment methods, and Chinese-language support are not disclosed. If CTIN is to be used for clinical trials in China, teams should additionally assess data export requirements, medical data compliance, and local deployment needs. Comparable options include Medidata, Clario, ICON Medical Imaging, Imaging Endpoint, as well as domestic eClinical platforms and clinical trial imaging review solutions.